US · Healthcare

Fiore Cannabis Ltd (FIORF)

Drug Manufacturers - Specialty & Generic

Fiore Cannabis Ltd (FIORF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for FIORF

P/E ratio

18.00

Fiore Cannabis Ltd (FIORF) — FAQ

What is FIORF's P/E ratio?

The price-to-earnings (P/E) ratio for Fiore Cannabis Ltd (FIORF) is 18.00 (data as of 2026-03-24).

Does Fiore Cannabis Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Fiore Cannabis Ltd (FIORF). Check the MyAverix Finance app for the latest dividend data.

What sector is Fiore Cannabis Ltd in?

Fiore Cannabis Ltd (FIORF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is FIORF listed on?

FIORF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)